Keywords: مازالازین; Ulcerative proctitis; Mesalazine; Suppositories; Topical treatment; Proctitis ulcerosa; Mesalazina; Supositorios; Tratamiento tópico;
مقالات ISI مازالازین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مازالازین; Ulcerative proctitis; Mesalazine; Suppositories; Topical treatment; Proctitis ulcerosa; Mesalazina; Supositorios; Tratamiento tópico;
Keywords: مازالازین; Drug release; Mesalazine; Composite;
Keywords: مازالازین; Tetraethoxysilane (PubChem CID: 6517); Ethanol (PubChem CID: 702); Hydrochloric acid (PubChem CID: 313); Sodium metasilicate (PubChem CID: 23266); Sodium chloride (PubChem CID: 5234); Potassium dihydrogen phosphate (PubChem CID: 516951); Calcium chloride
Keywords: مازالازین; Mesalazine; 5-Aminosalicylic acid; Metabolite; Carbon nanotubes; Nafion; Voltammetry
Keywords: مازالازین; Ulcerative colitis; Inflammatory bowel disease; Mesalazine; 5-ASA; Cost analysisColitis ulcerosa; Enfermedad inflamatoria intestinal; Mesalazina; 5-ASA; Análisis de costes
Keywords: مازالازین; Abscess; colitis; diverticulitis; diverticulosis; haemorrhage; mesalazine; pericolitis; probiotic; rifaximin
Keywords: مازالازین; Diverticular disease; Diverticulitis; Treatment; Prevention; Rifaximin; Mesalazine; ProbioticsEnfermedad diverticular; Diverticulitis; Tratamiento; Prevención; Rifaximina; Mesalazina; Probioticos
Keywords: مازالازین; Mesalazine; Once daily; Active disease; Ulcerative colitis
Keywords: مازالازین; Mesalazine; Oral; Rectal suspension; Ulcerative colitis; Mucosal healing;
Keywords: مازالازین; ECCO; European Crohn's and Colitis Organisation; UC; ulcerative colitis; UC-DAI; Ulcerative Colitic Disease Activity Index; Evidence-based; Recommendations; Guidelines; Prescribing; Intervention; Mesalazine;
Keywords: مازالازین; CD; Crohn's Disease; CDAI; Crohn's Disease Activity Index; CRP; C-reactive protein; ECCO; European Crohn's and Colitis Organisation; NPV; negative predictive value; PPV; positive predictive value; TNF-α; tumor necrosis factor alpha.; Crohn's; Clinical co
Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity
Keywords: مازالازین; Mesalazine; Hydroxypropyl-β-cyclodextrin; Chitosan; Nanoparticles; Sustained release; Anti-inflammatory;
Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats
Keywords: مازالازین; Liver fibrosis; Mesalazine; Osteopontin; Antioxidants; TGF-β1;
Ziziphus spina-christi fruit extract suppresses oxidative stress and p38 MAPK expression in ulcerative colitis in rats via induction of Nrf2 and HO-1 expression
Keywords: مازالازین; AcOH; acetic acid; ARE; antioxidant responsive element; Cas-3; caspase-3; CAT; catalase; CMIS; colonic mucosal injury score; COX; cyclooxygenase; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; GRd; glutathione reductase; GPx; glutathione peroxidase; H&E
CTAB immobilized carbon paste electrode for the determination of mesalazine: A cyclic voltammetric method
Keywords: مازالازین; Cetyltrimethyl ammonium bromide; Mesalazine; Carbon paste electrode; Cyclic voltammetry;
Requerimientos terapéuticos en el tratamiento de mantenimiento de la proctitis ulcerosa
Keywords: مازالازین; Proctitis ulcerosa; Mesalazina; Tratamiento tópico; Mantenimiento; Ulcerative proctitis; Mesalazine; Topical therapy; Maintenance;
A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems
Keywords: مازالازین; SBA-16NH2; Surface modification; Eudragit coating; Mesalazine; Drug–carrier interaction
Determination of mesalazine, a low bioavailability olsalazine metabolite in human plasma by UHPLC–MS/MS: Application to a pharmacokinetic study
Keywords: مازالازین; Mesalazine; Derivatization; Human plasma; Method validation; LC–MS/MS; Pharmacokinetics
Falsa hipersensibilidad a mesalazina como causa de escalamiento terapéutico
Keywords: مازالازین; Mesalazina; Colitis ulcerosa; Hipersensibilidad; Mesalazine; Ulcerative colitis; Hypersensitivity;
Alimentary TractA randomized trial comparing 4.8 vs. 2.4Â g/day of oral mesalazine for maintenance of remission in ulcerative colitis
Keywords: مازالازین; Daily dosage; Maintenance of remission; Mesalazine; Ulcerative colitis;
Recomendaciones sobre el uso e indicaciones del tratamiento tópico en pacientes con colitis ulcerosa
Keywords: مازالازین; Tratamiento tópico; Colitis ulcerosa; Mesalazina; Corticoides; Topical treatment; Ulcerative colitis; Mesalazine; Corticosteroids;
Synthesis and QSAR study of novel anti-inflammatory active mesalazine–metronidazole conjugates
Keywords: مازالازین; Mesalazine; Metronidazole; Conjugates; Amino acids; Anti-inflammatory; QSAR
Pneumopathie organisée apparue sous mésalazine
Keywords: مازالازین; Pneumopathie organisée cryptogénique; Mésalazine; Rectocolite ulcéro-hémorragique; Pneumopathies interstitielles; Iatrogénie; Cryptogenic organizing pneumonia; Mesalamine; Colitis ulcerative; Interstitial pneumonia; Iatrogenic diseases;
Rescate con sulfasalazina antes de inmunosupresores o agentes biológicos en la colitis ulcerosa mal controlada con mesalazina
Keywords: مازالازین; Enfermedad inflamatoria intestinal; Colitis ulcerosa; Sulfasalazina; Mesalazina; Inflammatory bowel disease; Ulcerative colitis; Sulfasalazine; Mesalazine;
A novel coating concept for ileo-colonic drug targeting: Proof of concept in humans using scintigraphy
Keywords: مازالازین; Gastro resistant coatings; Double coating; Modified release; Colonic delivery; Mesalazine; Biorelevant dissolution
Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing
Keywords: مازالازین; Mesalazine; 5-ASA; Ulcerative colitis; Left-sided; Mucosal healing;
Diverticular disease
Keywords: مازالازین; abscess; colitis; diverticula; diverticulitis; diverticulosis; haemorrhage; mesalazine; pericolitis; probiotic; rifaximin
Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines
Keywords: مازالازین; 5-Aminosalicylic acid; Aspirin; Mebeverine; Mesalazine; Sulphasalazine;
Personalised MedicinesLayered lipid microcapsules for mesalazine delayed-release in children
Keywords: مازالازین; Mesalazine; Lipid; Microcapsules; Spray-congealing; Excipient microparticles; Delayed-release;
Interaction between Eudragit® E100 and anionic drugs: Addition of anionic polyelectrolytes and their influence on drug release performance
Keywords: مازالازین; polyelectrolytes; complexation; diffusion; Eudragit; carbomer; mesalazine; controlled release and dissolution rate;
Review ArticleThe clinical implication of drug dependency in children and adults with inflammatory bowel disease: A review
Keywords: مازالازین; IBD; inflammatory bowel disease; CD; Crohn's disease; UC; ulcerative colitis; Dependency; Corticosteroids; Infliximab; Mesalazine; Inflammatory bowel disease; Surgery;
Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease
Keywords: مازالازین; Mesalamine; Mesalazine; RCT; Remission; CI; confidence interval; CRP; C-reactive protein; CYP; cytochrome P450; ITT; intent-to-treat; LOCF; last observation carried forward; MDR1; multidrug resistance 1 gene; OD; once daily; PP; per protocol;
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: A real-life survey in Spain
Keywords: مازالازین; UC; Ulcerative Colitis; ECCO; European Crohn's and Colitis Organisation; GG; General Gastroenterologist; GSIBD; Gastroenterologist Specialised in inflammatory Bowel disease; IBD; Inflammatory Bowel Disease; NA; Not Applicable; 5-ASA; 5-aminosalicylic acid
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Keywords: مازالازین; Crohn's disease; Mesalazine; Steroids; Budesonide; Azathioprine; Infliximab; Adalimumab; Surgery;
Physiological bicarbonate buffers: stabilisation and use as dissolution media for modified release systems
Keywords: مازالازین; Bicarbonate buffers; Biorelevant dissolution; In vitro–in vivo correlations; 5-Aminosalicylic acid; Mesalamine; Mesalazine; Modified release; Enteric polymers; Poly(methacrylic acid methyl methacrylate); Eudragit S; Eudragit L; Colonic delivery
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial
Keywords: مازالازین; Cost; Economic evaluation; Ulcerative colitis; Cost-effectiveness analysis; Mesalazine
Long-term prevention of post-operative recurrence in Crohn's disease cannot be affected by mesalazine
Keywords: مازالازین; Crohn's disease;; Post-operative recurrence;; Clinical recurrence;; Surgical recurrence;; Mesalazine;
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial
Keywords: مازالازین; Cost; Economic evaluation; Ulcerative colitis; Cost-effectiveness analysis; Mesalazine; Cost-utility analysis;
Myopéricardite ou nécrose sous-endocardique : apport de l’imagerie par résonance magnétique illustré par un cas clinique
Keywords: مازالازین; Myopéricardite; Infarctus myocardique; Maladie inflammatoire digestive; Mésalazine; Imagerie par résonance magnétique; Syndrome coronarien aiguMyopericarditis; Myocardial infarction; Inflammatory bowel disease; Mesalazine; Magnetic resonance imaging; Acut
Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?
Keywords: مازالازین; Ulcerative colitis; Therapy; 5-Aminosalicylate; Mesalazine; MMX; Once daily; Compliance
Effect of mesalazine on epithelial cell proliferation in colonic diverticular disease
Keywords: مازالازین; Cell proliferation; Colonic mucosa; Diverticular disease; Mesalazine; Treatment
Delayed Release Tablet Dissolution Related to Coating Thickness by Terahertz Pulsed Image Mapping
Keywords: مازالازین; Asacol; mesalamine; mesalazine; delayed release; terahertz pulsed imaging; coating mapping; mean dissolution time (MDT); process analytical technology (PAT);
Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma
Keywords: مازالازین; Mesalazine; HPLC-ESI-MS/MS; Method validation; Pharmacokinetic; IBD
European evidence-based Consensus on the management of ulcerative colitis: Current management
Keywords: مازالازین; Ulcerative colitis; Acute severe colitis; Mesalazine; Azathioprine; Infliximab; Ileal pouch-anal anastomosis;
A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products
Keywords: مازالازین; Mesalazine; 5-Aminosalicylic acid; Drug release; Dissolution; Simulation; Colon; Biorelevant media
Evaluation of alginate based mesalazine tablets for intestinal drug delivery
Keywords: مازالازین; Mesalazine; Alginate; Intestinal drug delivery; X-ray imaging
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study
Keywords: مازالازین; Distal ulcerative colitis; Double-blind study; Mesalazine; Topical beclomethasone diproprionate
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis
Keywords: مازالازین; High risk of relapse; Mesalazine; Ulcerative colitis;
Exploiting gastrointestinal bacteria to target drugs to the colon: An in vitro study using amylose coated tablets
Keywords: مازالازین; Amylose; Starch; Mesalazine; Microflora; Colonic delivery; Film coating;